Post-Allogeneic Stem Cell Transplant Outcomes in Patients Treated with Hypomethylating Agent Plus Venetoclax Compared to CPX-351 von Jain, Akriti G, Ball, Somedeb, Aguirre, Luis E.E., Kuykendall, Andrew, Chan, Onyee, Komrokji, Rami S., Padron, Eric, Sallman, David A., Lancet, Jeffrey E., Mishra, Asmita, Sweet, Kendra

Volltext

Gender Disparities in Myelodysplastic Syndromes: Phenotype, Genotype, and Outcomes von Tinsley-Vance, Sara Marie, Ali, Najla Al, Ball, Somedeb, Aguirre, Luis E.E., Jain, Akriti G, Kaldas, David, Chan, Onyee, Padron, Eric, Sweet, Kendra, Lancet, Jeffrey E., Kuykendall, Andrew T., Sallman, David A., Komrokji, Rami S.

Volltext

A Focus on Phenotype and Genotype: Racial /Ethnic Disparities in Myelodysplastic Syndromes von Tinsley-Vance, Sara Marie, Ali, Najla Al, Ball, Somedeb, Jain, Akriti G, Aguirre, Luis E.E., Kaldas, David, Chan, Onyee, Padron, Eric, Sweet, Kendra, Lancet, Jeffrey E., Kuykendall, Andrew T., Sallman, David A., Komrokji, Rami S.

Volltext

Outcome with Hypomethylating Agent and Venetoclax Combination in Patients with Chronic Myelomonocytic Leukemia von Ball, Somedeb, Jain, Akriti G, Aguirre, Luis E.E., Ali, Najla Al, Zhang, Yumeng, Chan, Onyee, Kuykendall, Andrew T., Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Swoboda, David, Komrokji, Rami S., Sallman, David A.

Volltext

Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes von Aguirre, Luis E.E., Jain, Akriti G, Ball, Somedeb, Al Ali, Najla, Tinsley-Vance, Sara Marie, Sallman, David A., Sweet, Kendra, Lancet, Jeffrey E., Padron, Eric, Kuykendall, Andrew T., Komrokji, Rami S.

Volltext

Clinical Characteristics and Outcome of Patients with EZH2- Mutant Myelodysplastic Syndromes von Ball, Somedeb, Aguirre, Luis E.E., Jain, Akriti G, Hussaini, Mohammad O, Ali, Najla Al, Tinsley-Vance, Sara Marie, Chan, Onyee, Kuykendall, Andrew T., Sweet, Kendra, Lancet, Jeffrey E., Sallman, David A., Padron, Eric, Komrokji, Rami S.

Volltext

Outcome with Intensive Chemotherapy Compared to Hypomethylating Agent- Based Induction in Patients Aged 70 Years or Older with Newly Diagnosed Favorable Risk Acute Myeloid Leukemia von Ball, Somedeb, Jain, Akriti G, Aguirre, Luis E.E., Al Ali, Najla, Bewersdorf, Jan Philipp, Hayden, Alexander, Siddon, Alexa J., Lykon, Jillian, Madarang, Ellen, Sallman, David A., Padron, Eric, Sweet, Kendra, Lancet, Jeffrey E., Watts, Justin M, Swoboda, David M, Pollyea, Daniel A., Zeidan, Amer M., Komrokji, Rami S.

Volltext